tirzepatide nash mash in the SYNERGY-NASH trial, researchers assessed the efficacy and safety of once-weekly Emerging Role of GLP-1 Receptor – Tirzepatide for MASH with Liver

JULIA: Hola, Laura

doi: 10.3389/fphar.2026.1785129 Received 11 January 2026 Revised 18 February 2026 Accepted 02 March 2026 Published 23 March 2026 Volume 17 - 2026 Edited by Anick Brard, Montreal University, Canada Reviewed by Surendra Rajpurohit, Augusta University, United States Ayman R Fath, Minneapolis Heart Institute Foundation (MHIF), United States Updates Copyright 2026 Chen, Wang, Xie, Chen, Luo and Xu

Once absorbed, the active ingredients begin supporting hydration, barrier repair, brightening, and skin elasticity

Shop healthy brands New and trending Discover your healthy Can muscle mass really support longevity

The pharmaceutical industry was never going to allow this anti-obesity duopoly to make a fortune forever